JP2012176989A5 - - Google Patents

Download PDF

Info

Publication number
JP2012176989A5
JP2012176989A5 JP2012137788A JP2012137788A JP2012176989A5 JP 2012176989 A5 JP2012176989 A5 JP 2012176989A5 JP 2012137788 A JP2012137788 A JP 2012137788A JP 2012137788 A JP2012137788 A JP 2012137788A JP 2012176989 A5 JP2012176989 A5 JP 2012176989A5
Authority
JP
Japan
Prior art keywords
formula
compound
temperature
heating
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012137788A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012176989A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012176989A publication Critical patent/JP2012176989A/ja
Publication of JP2012176989A5 publication Critical patent/JP2012176989A5/ja
Withdrawn legal-status Critical Current

Links

JP2012137788A 2006-08-14 2012-06-19 5−(1(s)−アミノ−2−ヒドロキシエチル)−n−[(2,4−ジフルオロフェニル)−メチル]−2−[8−メトキシ−2−(トリフルオロメチル)−5−キノリン]−4−オキサゾールカルボキサミドの塩 Withdrawn JP2012176989A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83766106P 2006-08-14 2006-08-14
US60/837,661 2006-08-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009524638A Division JP2010500406A (ja) 2006-08-14 2007-08-10 5−(1(s)−アミノ−2−ヒドロキシエチル)−n−[(2,4−ジフルオロフェニル)−メチル]−2−[8−メトキシ−2−(トリフルオロメチル)−5−キノリン]−4−オキサゾールカルボキサミドの塩

Publications (2)

Publication Number Publication Date
JP2012176989A JP2012176989A (ja) 2012-09-13
JP2012176989A5 true JP2012176989A5 (enExample) 2012-12-27

Family

ID=38895795

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009524638A Withdrawn JP2010500406A (ja) 2006-08-14 2007-08-10 5−(1(s)−アミノ−2−ヒドロキシエチル)−n−[(2,4−ジフルオロフェニル)−メチル]−2−[8−メトキシ−2−(トリフルオロメチル)−5−キノリン]−4−オキサゾールカルボキサミドの塩
JP2012137788A Withdrawn JP2012176989A (ja) 2006-08-14 2012-06-19 5−(1(s)−アミノ−2−ヒドロキシエチル)−n−[(2,4−ジフルオロフェニル)−メチル]−2−[8−メトキシ−2−(トリフルオロメチル)−5−キノリン]−4−オキサゾールカルボキサミドの塩
JP2012247215A Pending JP2013032394A (ja) 2006-08-14 2012-11-09 5−(1(s)−アミノ−2−ヒドロキシエチル)−n−[(2,4−ジフルオロフェニル)−メチル]−2−[8−メトキシ−2−(トリフルオロメチル)−5−キノリン]−4−オキサゾールカルボキサミドの塩

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009524638A Withdrawn JP2010500406A (ja) 2006-08-14 2007-08-10 5−(1(s)−アミノ−2−ヒドロキシエチル)−n−[(2,4−ジフルオロフェニル)−メチル]−2−[8−メトキシ−2−(トリフルオロメチル)−5−キノリン]−4−オキサゾールカルボキサミドの塩

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012247215A Pending JP2013032394A (ja) 2006-08-14 2012-11-09 5−(1(s)−アミノ−2−ヒドロキシエチル)−n−[(2,4−ジフルオロフェニル)−メチル]−2−[8−メトキシ−2−(トリフルオロメチル)−5−キノリン]−4−オキサゾールカルボキサミドの塩

Country Status (11)

Country Link
US (1) US7956189B2 (enExample)
EP (1) EP2069337A1 (enExample)
JP (3) JP2010500406A (enExample)
CN (1) CN101522671A (enExample)
AR (1) AR062373A1 (enExample)
CA (1) CA2660703A1 (enExample)
CL (1) CL2007002366A1 (enExample)
MX (1) MX2009001770A (enExample)
PE (1) PE20080424A1 (enExample)
TW (1) TW200819446A (enExample)
WO (1) WO2008021271A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2393768T3 (es) 2005-05-26 2012-12-27 Neuron Systems, Inc Derivado de quinolina para el tratamiento de enfermedades retinianas
CA2782015C (en) 2009-12-11 2020-08-25 Neuron Systems, Inc. Topical ophthalmic compositions and methods for the treatment of macular degeneration
JP2015524400A (ja) * 2012-07-19 2015-08-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 9−[4−(3−クロロ−2−フルオロ−フェニルアミノ)−7−メトキシ−キナゾリン−6−イルオキシ]−1,4−ジアザ−スピロ[5.5]ウンデカン−5−オンのフマル酸塩、その薬物としての使用及び調製
HK1217439A1 (zh) 2013-01-23 2017-01-13 Aldeyra Therapeutics, Inc. 与毒性醛相关的疾病和治疗
CN118724806A (zh) 2015-08-21 2024-10-01 奥尔德拉医疗公司 氘化化合物和其用途
AU2018348174A1 (en) 2017-10-10 2020-04-23 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
AU2019319740A1 (en) 2018-08-06 2021-03-25 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
CA3137301A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CA3175856A1 (en) 2020-05-13 2021-11-18 Todd Brady Pharmaceutical formulations and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060241A1 (es) 2004-05-18 2006-04-01 Schering Corp 2-quinolil-oxazoles sustituidos como inhibidores de pde4

Similar Documents

Publication Publication Date Title
JP2012176989A5 (enExample)
JP2012067131A5 (enExample)
JP2018024682A5 (enExample)
JP2019104748A5 (enExample)
JP2012531408A5 (enExample)
JP2011518833A5 (enExample)
JP2015512931A5 (enExample)
JP2012530705A5 (enExample)
JP2013543842A5 (enExample)
JP2014515013A5 (enExample)
JP2012020997A5 (enExample)
JP2010501519A5 (enExample)
JP2012513416A5 (enExample)
JP2013541592A5 (enExample)
JP2015523382A5 (enExample)
JP2016503010A5 (enExample)
JP2013538849A5 (enExample)
JP2012528813A5 (enExample)
JP2010500406A5 (enExample)
JP2014530818A5 (enExample)
TWI455890B (zh) 雙金屬改質的二氧化鈦及其製備方法
JP2016510768A5 (enExample)
JP2016537326A5 (enExample)
JP2015516425A5 (enExample)
JP2013541589A5 (enExample)